ContraFect Corporation ContraFect Corporation Nasdaq: CFRX

Navigate ContraFect Corporation

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Lysins
    • Amurins
    • Publications / Posters
    • Video Library
  • Pipeline
    • Overview
    • Exebacase
    • CF-370
    • Gram-negative Lysins
    • Amurins
  • Investors & Media
    • Overview
    • News / Events
    • Presentations
    • Company Information
    • Financial Information
    • Analyst Coverage
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us

Press Releases

Investors & Media

  • Home
  • Investors & Media
  • News / Events
  • Press Releases
Investors & Media

Investors & Media

  • Overview
  • News / Events
    • Press Releases
    • Media Coverage
    • Events
    • Email Alerts
  • Presentations
  • Company Information
  • Financial Information
  • Analyst Coverage
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010

ContraFect Announces Organizational Changes

September 16, 2016

ContraFect Announces Second Quarter 2016 Results

August 9, 2016

ContraFect Receives Designation as a Small and Medium Enterprise by the European Medicines Agency

August 4, 2016

ContraFect Corporation Prices $35 Million Public Offering of Common Stock and Warrants

July 22, 2016

ContraFect Corporation Names Steven C. Gilman, PhD Chief Executive Officer

July 21, 2016

ContraFect Corporation Announces Proposed Public Offering of Common Stock and Warrants

July 21, 2016

ContraFect Presents New CF-301 Data at ASM Microbe 2016

June 21, 2016

ContraFect Announces Presentation of Data at ASM Microbe 2016

June 8, 2016

ContraFect to Present at Jefferies 2016 Healthcare Conference

June 1, 2016

ContraFect Announces First Quarter 2016 Results

May 10, 2016

RSS
  • « Previous
  • 1...
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • ...23
  • Next »
© 2023 ContraFect Corporation. All Rights Reserved.
Copyright Privacy Policy Expanded Access Policy Disclaimer Site Map
LinkedIn Twitter